Breaking News

Diadem Biotherapeutics Awarded the First Amgen Golden Ticket

Will receive one year of lab space at BioLabs LA at The Lundquist Institute and additional facility benefits and connections to Amgen's scientific leaders.

Author Image

By: Kristin Brooks

Managing Editor, Contract Pharma

Amgen and The Lundquist Institute have awarded Diadem Biotherapeutics, Inc. with the first Amgen Golden Ticket in Southern California. Diadem will receive one year of lab space at BioLabs LA at The Lundquist Institute (TLI) as well as additional facility benefits and connections to Amgen’s scientific and business leaders.   The 2021 Amgen Golden Ticket winner was chosen by an internal team of Amgen scientific leaders. Five finalists pitched their business plans before Amgen’s inter...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters